Cullinan Therapeutics, Inc. (CGEM)
13.66
-0.22
(-1.59%)
USD |
NASDAQ |
Feb 20, 16:00
13.50
-0.16
(-1.17%)
After-Hours: 20:00
Cullinan Therapeutics EPS Diluted (Quarterly) : -0.8567 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Amgen, Inc. | 2.455 |
| Regeneron Pharmaceuticals, Inc. | 7.857 |
| MacroGenics, Inc. | 0.2658 |
| Xencor, Inc. | -0.081 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -50.61M |
| Total Expenses (Quarterly) | 50.61M |
| Enterprise Value | 488.57M |
| Earnings Yield | -26.94% |
| Normalized Earnings Yield | -26.94 |